OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Gastroenterology & Hepatology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Small bowel transplant – novel indications and recent progress	47
Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how?	38
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors	33
Managing pain in irritable bowel syndrome: current perspectives and best practice	31
Leucine-rich alpha-2 glycoprotein as a blood biomarker in inflammatory bowel disease: clinical implications and future perspectives	30
Impact of yoga therapy in intestinal disorders	27
Targeting liver metabolism: a pathway to cure hepatitis B virus?	26
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions	26
Therapeutic drug monitoring in inflammatory bowel disease: recent developments	26
Addressing current limitations of colonoscopy for colorectal cancer screening	26
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis	25
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences	25
Irritable bowel syndrome – controversies in diagnosis and management	25
Recent advances in treating constipation in children	24
Gender-related differences in celiac disease presentation and follow-up in adult patients	23
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease	22
Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms	22
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?	22
The assessment of impaired liver function and prognosis in hepatocellular carcinoma	21
A narrative review on the diagnosis and management of constipation in infants	20
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)	20
Elucidating the role of extracellular vesicles in liver injury induced by HIV	20
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites	20
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management	19
Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities	18

Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont	18
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction	18
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract	18
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment	18
Investigating the correlation between COVID-19 and the progression of chronic liver disease	17
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice	17
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?	17
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice	17
Managing bile acid diarrhea: aspects of contention	16
The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review	16
Small bowel imaging in inflammatory bowel disease: updates for 2023	15
IBD in women of reproductive age: where do novel therapies fit in?	15
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	15
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis	15
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis	15
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective	14
Psychological distress in inflammatory bowel disease	14
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States	14
Updates on intestinal failure management	14
The impact of a multidisciplinary team evaluation on the diagnosis and management of acute and chronic pancreatitis in a tertiary referral center	14
Evaluating the role of endoscopic ultrasound in pancreatitis	14
Highlights of the drug-induced liver injury literature for 2021	13
Managing pediatric Crohn’s disease: recent insights	13
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery	13
Techniques and outcomes review of the endoscopic management of gastrointestinal bleeding	12
Carcinoid syndrome mimicking irritable bowel syndrome: don’t fall into the trap	12
Artificial intelligence implementation in pancreaticobiliary endoscopy	12
Noninvasive diagnosis of clinically significant portal hypertension: current evidence and future directions	12
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives	12
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review	11
Gastroesophageal reflux disease in preterm infants: unmet needs	11
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis	11
Diagnosing eosinophilic esophagitis in pediatric patients	11
Managing complications of chronic pancreatitis: a guide for the gastroenterologist	11
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults	11
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma	11
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays	11
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges	10
Reply to letter to the Editor: Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	10
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece	10
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases	10
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art	10
Management of disease-related abdominal abscesses in Crohn’s disease	10
Towards a better diagnosis of gastro esophageal reflux disease	9
Highlighting novel targets in immunotherapy for liver cancer	9
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?	9
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study	9
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview	9
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis	9
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation	9

Radiation safety and dose management in fluoroscopy-guided gastrointestinal procedures: current evidence and future perspectives	8
Medical management of acute severe ulcerative colitis in the hospitalized patient	8
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease	8
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease	8
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights	8
Characterizing Crohn’s disease phenotypes through pan-enteric capsule endoscopy	8
Acute severe ulcerative colitis: defining the precise moment for colectomy	8
Clinical role of anti-PD-1 immunotherapies in esophageal cancer	8
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma	8
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis	8
Nutritional aspects of inflammatory bowel disease	8
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis	8
Endoscopic follow-up in patients with first-degree relatives for gastric cancer: a real-world observational study	8
Systematic mapping of worldwide research on intra-pancreatic fat deposition	8
The TL1A inhibitors in IBD: what’s in the pot?	8
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study	8
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity	8
Induction and maintenance of healing in erosive esophagitis in the United States	8
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review	8
Histamine-producing bacteria and their role in gastrointestinal disorders	8
Introducing the “Guideline Comparison” article type	8
Clinical management of inflammatory bowel disease from preconception to postpartum	8
Safety and use of IBD therapies during pregnancy and lactation	8
PSC patient with jaundice – should we ERCP?	8
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan	7
Short bowel syndrome-associated intestinal failure: diagnosis and prognosis	7
A contemporary review of care gaps in hepatocellular carcinoma surveillance	7
Before the scope: precision medicine in medication management for endoscopic safety and quality	7
Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI)	7
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review	7
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease	7
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review	7
Significance of nucleologenesis, ribogenesis, and nucleolar proteome in the pathogenesis and recurrence of hepatocellular carcinoma	7
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis	7
Recent advances in the treatment of gastrointestinal motility disorders in children	7
Adenoma detection rate in colonoscopy: how can it be improved?	7
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors	7
2023 update on the clinical management of gastroparesis	7
Prioritization in inflammatory bowel disease therapy	7
To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease	7
The eternal dichotomy between early biologic therapy and early surgery in Crohn’s disease: which should truly take precedence?	7
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease	7
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure	7
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms	7
Noninvasive electrical neuromodulation for gastrointestinal motility disorders	7
Proton beam therapy in the management of hepatocellular carcinoma	7
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect	7
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities	7